These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34273688)

  • 1. Drug screening by uniform patient derived colorectal cancer hydro-organoids.
    Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS
    Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
    Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
    Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.
    Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW
    Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
    Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
    J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
    Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
    SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
    Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
    STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
    Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
    J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids.
    Putker M; Millen R; Overmeer R; Driehuis E; Zandvliet MMJM; Clevers H; Boj SF; Li QX
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33999032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer.
    Toshimitsu K; Takano A; Fujii M; Togasaki K; Matano M; Takahashi S; Kanai T; Sato T
    Nat Chem Biol; 2022 Jun; 18(6):605-614. PubMed ID: 35273398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays.
    Brandenberg N; Hoehnel S; Kuttler F; Homicsko K; Ceroni C; Ringel T; Gjorevski N; Schwank G; Coukos G; Turcatti G; Lutolf MP
    Nat Biomed Eng; 2020 Sep; 4(9):863-874. PubMed ID: 32514094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly.
    Zhang XS; Xie G; Ma H; Ding S; Wu YX; Fei Y; Cheng Q; Huang Y; Wang Y
    Biofabrication; 2023 Aug; 15(4):. PubMed ID: 37552975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity.
    Jiang S; Zhao H; Zhang W; Wang J; Liu Y; Cao Y; Zheng H; Hu Z; Wang S; Zhu Y; Wang W; Cui S; Lobie PE; Huang L; Ma S
    Cell Rep Med; 2020 Dec; 1(9):100161. PubMed ID: 33377132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay establishment and validation of a high-throughput organoid-based drug screening platform.
    Li X; Fu G; Zhang L; Guan R; Tang P; Zhang J; Rao X; Chen S; Xu X; Zhou Y; Deng Y; Lv T; He X; Mo S; Mu P; Gao J; Hua G
    Stem Cell Res Ther; 2022 May; 13(1):219. PubMed ID: 35619149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Organoid Culture in Polymer Film-Based Microwell Arrays.
    Kakni P; Hueber R; Knoops K; López-Iglesias C; Truckenmüller R; Habibovic P; Giselbrecht S
    Adv Biosyst; 2020 Oct; 4(10):e2000126. PubMed ID: 32734713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uniform cerebral organoid culture on a pillar plate by simple and reproducible spheroid transfer from an ultralow attachment well plate.
    Acharya P; Joshi P; Shrestha S; Choi NY; Jeong S; Lee MY
    Biofabrication; 2024 Jan; 16(2):. PubMed ID: 38176079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer.
    Norkin M; Ordóñez-Morán P; Huelsken J
    Cell Rep; 2021 Apr; 35(3):109026. PubMed ID: 33882314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.